Stifel lowers Adient stock price target to $24 from $29, maintains Buy rating

Stifel lowered its price target on Adient (ADNT) to $24.00, while maintaining a Buy rating, following the automotive seating supplier's mixed fiscal Q4 2025 results and cautious FY2026 guidance. Although Adient's Q4 revenue and EPS surpassed expectations, adjusted EBITDA was slightly below, and its FY2026 EBITDA outlook fell "materially below" consensus due to anticipated production disruptions from supply chain issues. This conservative guidance led to the price target reduction and a pre-market stock decline, despite the Q4 EPS beat, indicating market concern over future profitability.

Analysis

Stifel lowered its price target for Adient (ADNT) to $24.00 from $29.00, while maintaining a Buy rating, following the company's mixed fiscal Q4 2025 results. Adient reported Q4 revenue of $3.7 billion, a 4% year-over-year increase, and EPS of $0.52, both exceeding analyst consensus. However, adjusted EBITDA of $226 million for the quarter came in slightly below expectations.

The primary driver for the price target reduction and the market's mildly negative sentiment (-0.3) is Adient's cautious fiscal year 2026 guidance. While FY26 revenue is projected to align with consensus, EBITDA is forecast to be "materially below" market expectations, reflecting management's incorporation of a "relatively negative scenario" due to customer supply chain issues. This conservative outlook overshadowed the Q4 EPS beat, leading to a pre-market stock decline.

Despite the reduced price target, Stifel's $24.00 target still suggests a significant upside from the current $19.09 share price, aligning with InvestingPro's Fair Value assessment. The firm noted potential for an upward revision to guidance if production disruptions stemming from supply chain issues abate throughout calendar year 2026, indicating a scenario-dependent outlook with potential for recovery.

Key Decisions for Investors

• Investors should closely monitor Adient's customer supply chain conditions and production recovery throughout calendar year 2026, as this is a key determinant for potential upward revisions to the conservative FY26 EBITDA guidance.
• Given Stifel's maintained "Buy" rating and the new $24.00 price target suggesting undervaluation at $19.09, investors should evaluate if the current market reaction presents a buying opportunity for long-term positions, considering the temporary nature of supply chain headwinds.
• Assess the risk-reward of a cautious outlook; while the near-term is impacted by supply chain risks, the company's ability to exceed Q4 revenue and EPS estimates suggests underlying operational strength.